{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:44:32Z","timestamp":1791045872147,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Overactive bladder (OAB) in men is a topic that is gaining increasing attention as there is a wider understanding that OAB is not a female condition. There are several treatments; however, data in male populations are lacking compared to female cohorts. The high likelihood of concomitant benign prostatic hyperplasia (BPH)\u00a0and benign prostatic obstruction (BPO) adds to the complexity of the treatment algorithm. The overlap in urinary storage symptoms also makes the interpretation of the literature challenging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Articles that evaluated men with OAB and men with OAB and BPH\/BPO were evaluated and assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Behavioral interventions can offer a significant benefit to male patients with OAB. Medical therapies that have been studied in men with OAB include anticholinergics, beta\u20103 agonists, and phosphodiesterase\u20105 inhibits. These agents can be offered in addition to alpha\u2010blockers for men with coexisting BPH\/BPO.\u00a0The literature on Onabotulinumtoxin\u2010A and neuromodulation modulation in the male population is growing and shows promising results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Male OAB is complex; however, there is a growing body of literature to help guide treatments. Many treatments are available and they have\u00a0shown considerable success.<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.25000","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T05:14:25Z","timestamp":1656911665000},"page":"1975-1982","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of overactive bladder in men: Is it really different?"],"prefix":"10.1002","volume":"41","author":[{"given":"Katherine K.","family":"Shapiro","sequence":"first","affiliation":[{"name":"Department of Urology New York University New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1699-3871","authenticated-orcid":false,"given":"Benjamin M.","family":"Brucker","sequence":"additional","affiliation":[{"name":"Department of Urology New York University New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02243-4"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.09.019"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.02228.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.08.039"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2016.04.001"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2004.74008.x"},{"key":"e_1_2_8_8_1","first-page":"S98","article-title":"Impact of overactive bladder on work productivity in the United States: results from EpiLUTS","volume":"15","author":"Sexton CC","year":"2009","journal-title":"Am J Manag Care"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.1998.7.1263"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00627-3"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03492.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000309"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02078.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002183"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2003.03076.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.02.028"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.6398"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03724.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000345050"},{"issue":"1","key":"e_1_2_8_20_1","first-page":"S129","article-title":"Safety and tolerability of solifenacin add\u2010on therapy to \u03b1\u2010blocker treated men with residual urgency and frequency","volume":"189","author":"Kaplan SA","year":"2013","journal-title":"J Urol"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.031"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01680.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02433.x"},{"issue":"4","key":"e_1_2_8_24_1","first-page":"5316","article-title":"Do effects of oxybutynin on cognition depend on the route of administration: topical or oral? [abstract no. P15]. Mid\u2010Atlantic Section of the American Urological Association 68th Annual Meeting","volume":"17","author":"Kay GG","year":"2010","journal-title":"Can J Urol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02626.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.03.020"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756287217702797"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018802"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.10.019"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000738"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.03.038"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.09.020"},{"key":"e_1_2_8_33_1","first-page":"1559","article-title":"Efficacy of tadalafil once daily versus fesoterodine in the treatment of overactive bladder in older patients","volume":"19","author":"Dell'atti L","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13489"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24285"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.08.005"},{"issue":"249","key":"e_1_2_8_37_1","first-page":"7","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double\u2010blind, placebo\u2010controlled trial","volume":"64","author":"Chapple C","year":"2013","journal-title":"Eur Urol"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.10.109"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000525"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13110"},{"key":"e_1_2_8_41_1","first-page":"75","article-title":"Clinical efficacy of transurethral resection of the prostate combined with oral anticholinergics or botulinum toxin\u2014a injection to treat benign prostatic hyperplasia with overactive bladder: a case\u2212control study","volume":"12","author":"Allameh F","year":"2020","journal-title":"Clin Pharmacol"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.08.054"},{"key":"e_1_2_8_43_1","doi-asserted-by":"crossref","unstructured":"HoffmanD EnemchukwuE NittiV.Predictors of urinary retention in male patients receiving intradetrusor botulinum toxin injections. abstract.J Urol.2017:PD39\u201011.","DOI":"10.1016\/j.juro.2017.02.1738"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.06.002"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.12.032"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-020-04429-8"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-1843-8"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.11.002"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.12482"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.25000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/nau.25000","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.25000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T21:24:44Z","timestamp":1692653084000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.25000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,3]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1002\/nau.25000"],"URL":"https:\/\/doi.org\/10.1002\/nau.25000","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,3]]},"assertion":[{"value":"2022-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}